143 related articles for article (PubMed ID: 37188167)
1. Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.
Deng M; Hinz F; Harrabi S; Sturm D; Sill M; Korshunov A; Eichkorn T; Hörner-Rieber J; Herfarth K; Jungk C; Unterberg A; Pfister S; Wick W; von Deimling A; Jones D; Debus J; Sahm F; König L
Neurooncol Pract; 2023 Jun; 10(3):307-314. PubMed ID: 37188167
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.
Ebrahimi A; Korshunov A; Reifenberger G; Capper D; Felsberg J; Trisolini E; Pollo B; Calatozzolo C; Prinz M; Staszewski O; Schweizer L; Schittenhelm J; Harter PN; Paulus W; Thomas C; Kohlhof-Meinecke P; Seiz-Rosenhagen M; Milde T; Casalini BM; Suwala A; Wefers AK; Reinhardt A; Sievers P; Kramm CM; Etminam N; Unterberg A; Wick W; Herold-Mende C; Sturm D; Pfister SM; Sill M; Jones DTW; Schrimpf D; Reuss DE; Aldape K; Abdullaev Z; Sahm F; von Deimling A; Stichel D
Acta Neuropathol Commun; 2022 Jan; 10(1):5. PubMed ID: 35012690
[TBL] [Abstract][Full Text] [Related]
3. Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach.
Reuss DE; Schrimpf D; Stichel D; Ebrahimi A; Dampier C; Aldape K; Snuderl M; Capper D; Sill M; Jones DTW; Pfister SM; Sahm F; von Deimling A
Free Neuropathol; 2023 Jan; 4():. PubMed ID: 38026572
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Pleomorphic Xanthoastrocytoma: A National Database Inquiry on Current Treatment Approaches in the United States.
Scarpelli DB; Yu Y; Tep AC; Bergue B; Degnin C; Chen Y; McClelland S; Jaboin JJ
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1415. PubMed ID: 33963808
[TBL] [Abstract][Full Text] [Related]
5. Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng MY; Hinz F; Maas SLN; Anil G; Sievers P; Conde-Lopez C; Lischalk J; Rauh S; Eichkorn T; Regnery S; Bauer L; Held T; Meixner E; Lang K; Hörner-Rieber J; Herfarth K; Jones D; Pfister SM; Jungk C; Unterberg A; Wick W; von Deimling A; Debus J; Sahm F; König L
Neurooncol Adv; 2023; 5(1):vdad059. PubMed ID: 37293256
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and surgical outcomes of high grade pleomorphic xanthoastrocytomas: a single-center experience with a systematic review.
Zuo P; Li T; Sun T; Wu W; Wang Y; Zhang M; Wu Z; Zhang J; Zhang L
Front Oncol; 2023; 13():1193611. PubMed ID: 37448517
[TBL] [Abstract][Full Text] [Related]
7. Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review.
Weng JC; Li D; Wang L; Wu Z; Wang JM; Li GL; Jia W; Zhang LW; Zhang JT
J Neurosurg; 2018 Oct; 131(3):695-705. PubMed ID: 30497189
[TBL] [Abstract][Full Text] [Related]
8. Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation.
Gandham EJ; Goyal-Honavar A; Beno D; Pai R; Balakrishan R; Jasper A; Gowri M; Moorthy RK; Chacko AG; Chacko G
World Neurosurg; 2022 Aug; 164():e922-e928. PubMed ID: 35618235
[TBL] [Abstract][Full Text] [Related]
9. Demography, Pattern of Care, and Survival in Patients with Xanthoastrocytoma: A Systematic Review and Individual Patient Data Analysis of 325 Cases.
Mallick S; Giridhar P; Benson R; Melgandi W; Rath GK
J Neurosci Rural Pract; 2019 Jul; 10(3):430-437. PubMed ID: 31595115
[No Abstract] [Full Text] [Related]
10. Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature.
Detti B; Scoccianti S; Maragna V; Lucidi S; Ganovelli M; Teriaca MA; Caini S; Desideri I; Agresti B; Greto D; Buccoliero AM; Puppa AD; Sardi I; Livi L
Radiol Med; 2022 Oct; 127(10):1134-1141. PubMed ID: 35951279
[TBL] [Abstract][Full Text] [Related]
11. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C
Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.
Gallo P; Cecchi PC; Locatelli F; Rizzo P; Ghimenton C; Gerosa M; Pinna G
Br J Neurosurg; 2013 Dec; 27(6):759-64. PubMed ID: 23514331
[TBL] [Abstract][Full Text] [Related]
14. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.
Dhawan S; Patil CG; Chen C; Venteicher AS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009229. PubMed ID: 31958162
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
Drexler R; Schüller U; Eckhardt A; Filipski K; Hartung TI; Harter PN; Divé I; Forster MT; Czabanka M; Jelgersma C; Onken J; Vajkoczy P; Capper D; Siewert C; Sauvigny T; Lamszus K; Westphal M; Dührsen L; Ricklefs FL
Neuro Oncol; 2023 Feb; 25(2):315-325. PubMed ID: 35868257
[TBL] [Abstract][Full Text] [Related]
16. Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma. Case report.
Macaulay RJ; Jay V; Hoffman HJ; Becker LE
J Neurosurg; 1993 Nov; 79(5):761-8. PubMed ID: 8410257
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography in three children with pleomorphic xanthoastrocytoma.
Etzl MM; Kaplan AM; Moss SD; Spataro J; Bonstelle CT; Lawson MA; Bandy DJ
J Child Neurol; 2002 Jul; 17(7):522-7. PubMed ID: 12269732
[TBL] [Abstract][Full Text] [Related]
18. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
[TBL] [Abstract][Full Text] [Related]
19. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
20. Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
Tang K; Kurland D; Vasudevaraja V; Serrano J; Delorenzo M; Radmanesh A; Thomas C; Spino M; Gardner S; Allen JC; Nicolaides T; Osorio DS; Finlay JL; Boué DR; Snuderl M
J Neuropathol Exp Neurol; 2020 Aug; 79(8):880-890. PubMed ID: 32594172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
